Abbott Laboratories - 37 Year Stock Price History | ABT
Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits. The latest closing stock price for Abbott Laboratories as of October 19, 2020 is 108.04.
- The all-time high Abbott Laboratories stock closing price was 111.29 on August 27, 2020.
- The Abbott Laboratories 52-week high stock price is 114.19, which is 5.7% above the current share price.
- The Abbott Laboratories 52-week low stock price is 61.61, which is 43% below the current share price.
- The average Abbott Laboratories stock price for the last 52 weeks is 91.32.
| Abbott Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2020 | 92.8957 | 86.9500 | 111.2900 | 62.8200 | 108.0400 | 24.38% |
| 2019 | 80.5399 | 69.5000 | 88.7400 | 66.2200 | 86.8600 | 20.09% |
| 2018 | 64.2198 | 58.7900 | 74.2700 | 56.2700 | 72.3300 | 26.74% |
| 2017 | 48.5437 | 39.0500 | 57.4700 | 39.0500 | 57.0700 | 48.58% |
| 2016 | 40.4946 | 42.9300 | 45.2900 | 36.3400 | 38.4100 | -14.47% |
| 2015 | 46.3063 | 44.9000 | 51.2000 | 39.0600 | 44.9100 | -0.24% |
| 2014 | 40.9545 | 38.2300 | 46.3700 | 35.8500 | 45.0200 | 17.45% |
| 2013 | 35.6540 | 32.0500 | 38.7100 | 32.0500 | 38.3300 | -41.48% |
| 2012 | 62.7592 | 56.7200 | 72.1300 | 54.1500 | 65.5000 | 16.49% |
| 2011 | 51.0656 | 47.8200 | 56.3300 | 45.1600 | 56.2300 | 17.37% |
| 2010 | 50.7320 | 54.4600 | 56.2400 | 45.8600 | 47.9100 | -11.26% |
| 2009 | 48.4288 | 53.5600 | 57.2500 | 41.5200 | 53.9900 | 1.16% |
| 2008 | 55.1625 | 55.8100 | 60.5000 | 49.4500 | 53.3700 | -4.95% |
| 2007 | 54.4193 | 48.9700 | 59.4300 | 48.9700 | 56.1500 | 15.27% |
| 2006 | 45.0284 | 39.5500 | 49.4800 | 39.5500 | 48.7100 | 23.54% |
| 2005 | 45.3700 | 46.6700 | 49.9900 | 37.6300 | 39.4300 | -15.48% |
| 2004 | 42.3562 | 46.7500 | 46.9900 | 38.3600 | 46.6500 | 0.11% |
| 2003 | 41.2709 | 40.0500 | 47.1500 | 34.3800 | 46.6000 | 16.50% |
| 2002 | 45.8684 | 55.8400 | 57.7000 | 31.0000 | 40.0000 | -28.25% |
| 2001 | 50.0663 | 48.1300 | 56.7700 | 42.0600 | 55.7500 | 15.09% |
| 2000 | 41.6982 | 35.0000 | 55.7500 | 29.6300 | 48.4400 | 33.41% |
| 1999 | 43.6333 | 48.7500 | 52.9400 | 33.3100 | 36.3100 | -25.90% |
| 1998 | 40.9077 | 33.7200 | 49.7500 | 33.3450 | 49.0000 | 49.62% |
| 1997 | 30.8148 | 25.1900 | 34.3150 | 25.1900 | 32.7500 | 29.06% |
| 1996 | 22.6483 | 20.8750 | 28.3750 | 19.3750 | 25.3750 | 21.91% |
| 1995 | 19.2416 | 16.3150 | 22.3150 | 15.6250 | 20.8150 | 27.58% |
| 1994 | 14.8357 | 14.4400 | 16.8150 | 13.0650 | 16.3150 | 10.12% |
| 1993 | 13.4211 | 15.1900 | 15.1900 | 11.5000 | 14.8150 | -2.47% |
| 1992 | 15.3475 | 16.8125 | 17.0300 | 13.5000 | 15.1900 | -11.78% |
| 1991 | 13.0176 | 10.8125 | 17.2175 | 9.9375 | 17.2175 | 53.04% |
| 1990 | 9.5320 | 8.6563 | 11.3750 | 7.8750 | 11.2500 | 32.35% |
| 1989 | 7.3855 | 5.9688 | 8.7663 | 5.8288 | 8.5000 | 41.28% |
| 1988 | 5.8545 | 6.0788 | 6.5000 | 5.3750 | 6.0163 | -0.25% |
| 1987 | 7.1870 | 5.9375 | 8.3600 | 5.3750 | 6.0313 | 5.74% |
| 1986 | 5.4847 | 4.2500 | 6.7963 | 3.9844 | 5.7038 | 33.48% |
| 1985 | 3.4075 | 2.5394 | 4.3831 | 2.5000 | 4.2731 | 63.76% |
| 1984 | 2.6840 | 2.8750 | 3.0000 | 2.3750 | 2.6094 | -7.73% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $194.174B | $31.904B |
| Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medtronic (MDT) | Ireland | $148.038B | 27.88 |
| Stryker (SYK) | United States | $83.980B | 32.56 |
| Boston Scientific (BSX) | United States | $54.995B | 31.77 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.550B | 0.00 |
| Baxter (BAX) | United States | $41.420B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $30.422B | 25.25 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $29.732B | 0.00 |
| Terumo (TRUMY) | Japan | $29.086B | 37.18 |
| ResMed (RMD) | United States | $26.198B | 37.98 |
| Sunny Optical Technology (SNPTF) | China | $17.297B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.198B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $16.518B | 74.71 |
| Insulet (PODD) | United States | $16.303B | 689.81 |
| DiaSorin S.p.A (DSRLF) | Italy | $12.169B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $11.080B | 0.00 |
| Quidel (QDEL) | United States | $10.708B | 56.72 |
| GN STORE NORD (GNNDY) | Denmark | $9.996B | 50.95 |
| William Demant Holdings (WILYY) | Denmark | $7.850B | 0.00 |
| Canopy Growth (CGC) | Canada | $6.603B | 0.00 |
| Perrigo (PRGO) | Ireland | $6.466B | 11.10 |
| Hill-Rom Holdings (HRC) | United States | $5.963B | 14.80 |
| Haemonetics (HAE) | United States | $4.755B | 31.68 |
| Envista Holdings (NVST) | United States | $4.286B | 29.23 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $4.232B | 0.00 |
| ICU Medical (ICUI) | United States | $4.170B | 31.82 |
| TG Therapeutics (TGTX) | United States | $3.824B | 0.00 |
| Neogen (NEOG) | United States | $3.788B | 62.10 |
| Abcam (ABCZY) | $3.534B | 0.00 | |
| National Vision Holdings (EYE) | United States | $3.282B | 510.13 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $2.964B | 0.00 |
| NuVasive (NUVA) | United States | $2.742B | 38.21 |
| Agios Pharmaceuticals (AGIO) | United States | $2.479B | 0.00 |
| DFB Healthcare Acquisitions (AHCO) | United States | $2.373B | 0.00 |
| AtriCure (ATRC) | United States | $1.828B | 0.00 |
| Owens & Minor (OMI) | United States | $1.649B | 36.94 |
| Cardiovascular Systems (CSII) | United States | $1.548B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.527B | 0.00 |
| Aphria (APHA) | Canada | $1.343B | 0.00 |
| MacroGenics (MGNX) | United States | $1.321B | 0.00 |
| InMode (INMD) | Israel | $1.269B | 32.02 |
| Quanterix (QTRX) | United States | $1.204B | 0.00 |
| Cerus (CERS) | United States | $1.068B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.988B | 0.00 |
| PetIQ (PETQ) | United States | $0.932B | 26.73 |
| BioLife Solutions (BLFS) | United States | $0.901B | 469.50 |
| Lantheus Holdings (LNTH) | United States | $0.892B | 12.36 |
| Meridian Bioscience (VIVO) | United States | $0.775B | 17.90 |
| Vapotherm (VAPO) | United States | $0.759B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.737B | 16.87 |
| LeMaitre Vascular (LMAT) | United States | $0.654B | 39.89 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.632B | 89.33 |
| Omeros (OMER) | United States | $0.628B | 0.00 |
| Surmodics (SRDX) | United States | $0.567B | 62.19 |
| Varex Imaging (VREX) | United States | $0.533B | 23.08 |
| Zynex (ZYXI) | United States | $0.488B | 42.61 |
| Aurora Cannabis (ACB) | Canada | $0.464B | 0.00 |
| Surface Oncology (SURF) | United States | $0.376B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.369B | 0.00 |
| HEXO (HEXO) | $0.361B | 0.00 | |
| Viemed Healthcare (VMD) | United States | $0.345B | 12.32 |
| Utah Medical Products (UTMD) | United States | $0.301B | 25.82 |
| InfuSystems Holdings (INFU) | United States | $0.264B | 50.31 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.257B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.249B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.230B | 0.00 |
| Bovie Medical (APYX) | United States | $0.203B | 0.00 |
| Exagen (XGN) | United States | $0.201B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.193B | 0.00 |
| Female Health (VERU) | United States | $0.179B | 0.00 |
| Chimerix (CMRX) | United States | $0.178B | 0.00 |
| Evolus (EOLS) | United States | $0.141B | 0.00 |
| Fonar (FONR) | United States | $0.137B | 18.16 |
| Liberty Health Sciences (LHSIF) | United States | $0.128B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.098B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.094B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.081B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.077B | 0.00 |
| United-Guardian (UG) | United States | $0.069B | 15.57 |
| Trinity Biotech (TRIB) | Ireland | $0.066B | 12.55 |
| MTech Acquisition (KERN) | United States | $0.065B | 0.00 |
| Brainsway (BWAY) | Israel | $0.065B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.059B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.028B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.028B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.020B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.020B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.018B | 0.00 |
| Myomo (MYO) | United States | $0.016B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
